CB Therapeutics is Drug Discovery in United States that focus on psychedelic medicines business. Founded in 2015. They cover business area such as operator, tryptamine, cannabinoid, their analog, various disease, next-generation biosynthetic production, psychedelic medicine, further clinical research, various serious health condition, mental health issue, healthspan.
2015
( 9 years old in 2024 )
Psychedelic Medicines
-
2717 Loker Avenue West
Suite A
Carlsbad, CA 92010
United States
Private
operatortryptaminecannabinoidtheir analogvarious diseasenext-generation biosynthetic productionpsychedelic medicinefurther clinical researchvarious serious health conditionmental health issuehealthspan
* We use standard office opening hours in near CB Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CB Therapeutics is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), CB Therapeutics business is focusing on Psychedelic Medicines.
CB Therapeutics headquarter office and corporate office address is located in 2717 Loker Avenue West Suite A Carlsbad, CA 92010 United States.
CB Therapeutics was founded in United States.
In 2024, CB Therapeutics is currently focus on psychedelic medicines sector.
Above is snippet of Google Trends for "psychedelic medicines" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CB Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.